Utvalda publikationer

GABAA field

Amrutkar et al, 2020
Anti-tremor action of subtype selective positive allosteric modulators of GABAA receptors in a rat model of essential tremor.
Cerebellum 19:265-274

Neumann et al, 2019
The delta-subunit selective GABAA receptor modulator, DS2, improves stroke recovery via an anti-inflammatory mechanism.
Frontiers in Neuroscience 13 (article 1133):1-13

Ahring et al, 2016
A pharmacological assessment of agonists and modulators at α4β2γ2 and α4β2d GABAA receptors: The challenge in comparing apples with oranges.
Pharmacological Research 111:563-576

Hartiadi et al, 2016
High and low GABA sensitivity α4β2d GABAA receptors are expressed in Xenopus laevis oocytes with divergent stoichiometries.
Biochemical Pharmacology 103:98-108

de Lucas et al, 2015
GABAA α5 subunit-containing receptors do not contribute to reversal of inflammatory-induced spinal sensitization as indicated by the unique selectivity profile of the GABAA receptor allosteric modulator NS16085.
Biochemical Pharmacology 93:370-379

Nicotinic field

van Hout et al, 2020
Characterization of AN6001, a positive allosteric modulator of α6β2-containing nicotinic acetylcholine receptors.
Biochemical Pharmacology 174 (article 113788):1-11

Sandager-Nielsen et al, 2020
Characterization of AN317, a novel selective agonist of α6β2-containing nicotinic acetylcholine receptors.
Biochemical Pharmacology 174 (article 113786):1-13

Maurer et al, 2017
Attenuation of nicotine taking and seeking in rats by the stoichiometry-selective alpha4beta2 nicotinic acetylcholine receptor positive allosteric modulator NS9283.
Psychopharmacology 234:475-484

Ahring et al, 2015
Engineered α4β2 nicotinic acetylcholine receptors as models for measuring agonist binding and effect at the orthosteric low-affinity α4-α4 interface.
Neuropharmacology 92:135-145

Rasmussen et al, 2014
Biophysical and pharmacological characterization of α6-containing nicotinic acetylcholine receptors expressed in HEK293 cells.
Brain Research 1542:1-11

Potassium Channel field

Brown et al, 2020
Pharmacology of small- and intermediate-conductance calcium-activated potassium channels.
Annual Review of Pharmacology and Toxicology 60:219-240

Nguyen et al, 2017
Potassium channel expression and function in microglia: plasticity and possible species variations.
Channels 11:305-315

Blomster et al, 2016
Quantification of the functional expression of the Ca2+-activated K+-channel KCa3.1 on microglia from adult human neocortical tissue.
Glia 64:2065-2078

Christophersen and Wulff, 2015
Pharmacological gating modulation of small- and intermediate-conductance Ca(2+)-activated K(+) channels (Kca2.x and Kca3.1).
Channels 9:336-43

Grunnet et al, 2014
Kv7 channels as targets for anti-epileptic and psychiatric drug-development.
European Journal of Pharmacology 726:133-137